GCSF after Kasai surgery for biliary atresia
Treatments studied
Part of Digestive system, Genetic & congenital clinical trials.
This study tests a medicine called GCSF (helps make white blood cells) in babies who have had Kasai surgery for biliary atresia. It aims to see if GCSF can improve liver function and overall outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have biliary atresia (a liver bile duct problem from birth).
- They need to have a Kasai surgery to open the bile ducts.
- No major heart, kidney, lung, or brain problems.
- No sickle cell anemia or similar blood diseases.
- No active infection when starting the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving umbilical cord stem cells during early Kasai surgery (a procedure to help drain bile) improves outcomes for infants with biliary atresia. It may help your baby's liver function and overall health.
This trial tests a new treatment using stem cells from umbilical cord blood or tissue, given to infants with biliary atresia during their Kasai surgery. The goal is to improve liver function and reduce the need for a liver transplant.
This study tests whether a special nutrition plan helps babies with biliary atresia recover better after Kasai surgery. It is for infants under 3 months old who are ready for surgery.
This trial studies whether giving oral antibiotics before symptoms start can lower the chance of cholangitis (bile duct infection/inflammation) after Kasai portoenterostomy. It may help protect your child’s bile flow and reduce painful or serious infections after surgery.
This trial tests whether a special nutritional support formula rich in medium-chain fats can help infants with biliary atresia after the Kasai procedure. It may support feeding and liver recovery during the early months after surgery.
This study looks at a specific pre-surgery blood marker called FGF19 (and related liver blood tests) in children with biliary atresia. The goal is to see whether the blood results before surgery can help predict how well children recover after surgery.
Hear when a new Granulocyte Colony Stimulating Factor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.